ALIVUS LIFE SCIENCES
|
The Current P/E Ratio of ALIVUS LIFE SCIENCES is 28.19.
| Share Price | ₹1,384.3 | Aug 14,2026 |
| Market Cap | ₹16,999.2 Cr | |
| Earnings-TTM | ₹603.0 Cr | TTM-Standalone Results |
| Price/Earnings | 28.19x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALIVUS LIFE SCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹16,999.2 Cr] as on Aug 14,2026
(/) Earnings [ ₹603.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 28.19x ]
Thus, for ALIVUS LIFE SCIENCES , the investors are currently willing to pay 28.19 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALIVUS LIFE SCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALIVUS LIFE SCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALIVUS LIFE SCIENCES
PE Ratio Performance Analysis for ALIVUS LIFE SCIENCES
- ALIVUS LIFE SCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 18.46x.
- ALIVUS LIFE SCIENCES 's operated at median p/e ratio of 20.17x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALIVUS LIFE SCIENCES 's p/e ratio peaked in Mar2025 at 27.24x.
- ALIVUS LIFE SCIENCES 's p/e ratio hit its five-year low in Mar2023 of 10.28x.
How does ALIVUS LIFE SCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALIVUS LIFE SCIENCES | 603.02 | 28.19 | 16,999.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 37.94 | 461,848.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 77.14 | 225,648.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 85.39 | 184,109.0 |
| CIPLA LTD | 3,364.84 | 34.81 | 117,139.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.66 | 100,328.0 |
| MANKIND PHARMA LTD | 2,055.11 | 48.63 | 99,945.0 |
| LUPIN LTD | 5,551.01 | 18.41 | 102,192.0 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 25.31 | 113,715.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.69 | 95,397.6 |
| LAURUS LABS LTD | 1,090.76 | 89.90 | 98,064.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALIVUS LIFE SCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.41x |
| Max industry PE | 89.90x |
| Median industry PE | 34.81x |
| Average industry PE | 45.74x |
You may also like the below Video Courses